Drawing for INFANDX

USPTO serial 97703511

INFANDX

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
STURMAN, MELISSA M
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with INFANDX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Warren Zitlau

WARREN ZITLAU CAHN & SAMUELS, LLP1100 17TH STREET, NW, SUITE 401WASHINGTON, DC 20036UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic reagents; veterinary diagnostic reagents; diagnostic preparations for medical or veterinary purposes; diagnostic biomarker reagents for medical purposes; diagnostic preparations for use in neonates for medical use; medical diagnostic reagent preparations for detecting metabolites for diagnosing asphyxia, hypoxic-ischemic encephalopathy, or brain injury; diagnostic kits comprised of medical diagnostic reagents for detecting metabolites for use in diagnosis of asphyxia, hypoxic-ischemic encephalopathy, or brain injuryACTIVE—
009Scientific apparatus, instruments and devices, in particular for research and experimental purposes, namely, photometers, fluorometers, flow meters, apparatus and instruments for electrophoresis and mass spectrometry, liquid chromatography instruments for laboratory use, gas chromatography instruments for laboratory use, plasmone resonance spectrometers, and electrodes; laboratory consumables for the aforementioned apparatus, instruments and devices, namely, laboratory filters, pipetting tips, and optical filters; research laboratory analyzers for measuring, testing and analyzing blood and other bodily fluidsACTIVE—
010Apparatus for blood analysis; medical diagnostic instruments for the analysis of body fluids; medical devices for use in treating or diagnosing asphyxia, hypoxic-ischemic encephalopathy, or brain injuryACTIVE—
044Medical services, in particular medical services relating to diagnostic processes, analytical procedures and processes for conducting medical laboratory trials and tests; medical assistance, in particular in pediatricsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 15, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 15, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 12, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 17, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 17, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 27, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 12, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 12, 2023DOCKASSIGNED TO EXAMINER—
Jan 1, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 8, 2022NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance